(129 days)
Not Found
No
The device description details a standard immunoassay method based on agglutination and absorbance changes, with no mention of AI or ML technologies.
No.
This device is an in vitro diagnostic test for the quantitative determination of C-reactive protein, used for detection and evaluation of conditions, not for treating them.
Yes
Explanation: The device is explicitly stated to be an "in vitro diagnostic test" for the "quantitative determination of C-reactive protein," which is "useful in the detection and evaluation of infection, tissue injury and inflammatory disorders." This directly indicates its use in diagnosing medical conditions.
No
The device is an in vitro diagnostic test kit that includes reagents (latex particles, antibodies, calibrators, controls) and is used with an automated chemistry analyzer. It is not solely software.
Yes, this device is an IVD (In Vitro Diagnostic).
Here's why:
- Intended Use/Indications for Use: The document explicitly states "CRP Vario is an in vitro diagnostic test..." and describes its use for the quantitative determination of C-reactive protein in human serum and plasma samples. This is a classic definition of an in vitro diagnostic test.
- Device Description: The description details a "latex in vitro diagnostic immunoassay" and how it works to measure CRP in human samples.
- Intended User/Care Setting: It is described as an "in-vitro test for professional use," further confirming its IVD nature.
- Performance Studies: The document mentions performance evaluations, which are typical for IVD devices to demonstrate their analytical performance.
- Predicate Device(s): The listing of predicate devices with K numbers indicates that this device is being compared to other legally marketed IVD devices.
All of these points strongly support the classification of this device as an In Vitro Diagnostic.
N/A
Intended Use / Indications for Use
CRP Calibrators (CRP Calibrator Set, CRP Calibrator US and CRP Calibrator WR) are intended to be used for the calibration of the CRP Vario for the quantitative determination of C-reactive protein in human serum and EDTA or lithium heparinized plasma samples.
CRP Vario is an in vitro diagnostic test for the quantitative determination of C-reactive protein in human serum and lithium heparin or EDTA plasma samples by immunoturbidimetry. Measurement of C-reactive protein is useful in the detection and evaluation of infection, tissue injury and inflammatory disorders.
CRP Control US is intended for use as an assayed quality control material for serum C-reactive protein analysis.
Product codes (comma separated list FDA assigned to the subject device)
DKC, JIS, JJY
Device Description
The Sentinel CRP Vario kit is a latex in vitro diagnostic immunoassay for the quantitative determination of C-reactive protein (CRP) in human serum and in heparinized and EDTAplasma. Human CRP antigens in the sample bind to the specific anti-CRP antibody absorbed to latex particles, and agglutination occurs. This agglutination is detected as an absorbance change when read on an automated chemistry analyzer at wavelengths between 550 - 580 nm. The magnitude of the change in absorbance is proportional to the quantity of CRP in the sample. The actual concentration is then determined by interpolation from a calibration curve prepared from calibrators of known concentration using the CRP Calibrator Set, CRP Calibrator US, or CRP Calibrator WR.
The Sentinel CRP Calibrator Set, CRP Calibrator US and CRP Calibrator WR are prepared by diluting purified CRP with normal human serum to reach CRP concentrations of 0.25, 0.5, 1.0, 2.0, 4.0, 8.0, 16.0, 32.0 and 48.0 mg/dL.
By using the CRP Vario with the Sentinel calibrator kits, each used with specific analyzer settings called Methods, three measuring ranges can be achieved. The combinations of calibrators, method used and analytical ranges are listed in Table 5.1.
Application Method | Calibrators | Analytical Range |
---|---|---|
Standard Method | CRP Calibrator Set | 0.02 – 32.0 mg/dL |
Ultrasensitive Method | CRP Calibrator Set and CRP Calibrator US | 0.01 – 16.0 mg/dL |
Wide Range Method | CRP Calibrator Set and CRP Calibrator WR | 0.02 – 48.0 mg/dL |
The Standard and the Wide Range Methods can be used with any available commercial quality control materials. The CRP Vario with the Ultrasensitive Method requires a Sentinel control, CRP Control US, for the approximate CRP concentration of 0.05 mg/dL to ensure the effectiveness of CRP measurements at very low CRP concentrations.
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Not Found
Anatomical Site
Not Found
Indicated Patient Age Range
Not Found
Intended User / Care Setting
professional use.
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)
Performance evaluations included sensitivity, intra- and inter-assay precision, prozone and interference testing. In addition, Sentinel performed comparisons between the Sentinel CRP assay and the Beckman Coulter IMMAGE Immunochemistry System CRP reagent. Equivalence was demonstrated across the total measurement range of0.01 to 48.0 mg/dL.
Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)
Not Found
Predicate Device(s): If the device was cleared using the 510(k) pathway, identify the Predicate Device(s) K/DEN number used to claim substantial equivalence and list them here in a comma separated list exactly as they appear in the text. List the primary predicate first in the list.
K030545, K030546, K981638, K011169
Reference Device(s): Identify the Reference Device(s) K/DEN number and list them here in a comma separated list exactly as they appear in the text.
Not Found
Predetermined Change Control Plan (PCCP) - All Relevant Information for the subject device only (e.g. presence / absence, what scope was granted / cleared under the PCCP, any restrictions, etc).
Not Found
§ 866.5270 C-reactive protein immunological test system.
(a)
Identification. A C-reactive protein immunological test system is a device that consists of the reagents used to measure by immunochemical techniques the C-reactive protein in serum and other body fluids. Measurement of C-reactive protein aids in evaluation of the amount of injury to body tissues.(b)
Classification. Class II (performance standards).
0
Image /page/0/Picture/0 description: The image shows the words "SENTINEL DIAGNOSTICS" and the date "AUG 8 - 2005". The words "SENTINEL DIAGNOSTICS" are written in a stylized font, with the letters appearing to be made of individual lines. The date "AUG 8 - 2005" is written in a more standard font and is located above the word "SENTINEL".
510k Summary Sentinel C-Reactive Protein (CRP) Diagnostic Assay
K Number: K050836
- Submitter's information: Mr. Ugo De Luca Managing Director Sentinel CH Srl Via Principe Eugenio 20155 Milan, Italy
Tel.: +39 02 345514 1 Fax: +39 02 345514 64 e-mail: sentinel@sentinel.it
-
Maria E. Donawa, M.D. 2. Contact person: Donawa Consulting Srl Piazza Albania, 10 00153 Rome, Italy
Tel.: +39 06 578 2665 Fax: +39 06 574 3786 e-mail: medonawa@donawa.com -
- Date summary prepared: 31 March 2005
4. Device name and classification
The CRP Diagnostic Assay described in this 510(k) consists of reagents, calibrators and a control. packaged and distributed in five kits, but together making up the CRP assay. The device is intended to be sold as an in-vitro test for professional use.
Product name and classification information are provided in Table 4.1 below.
Table 4.1 Device names and classification of Sentinel CRP DIAGNOSTIC ASSAY | |||||
---|---|---|---|---|---|
components | |||||
| Common or
usual name | Trade or
Proprietary Name | Classification
name | Class | Product
Code | Classification
panel |
|----------------------------|------------------------------|--------------------------------------------------------|------------------------------------------|-----------------|-------------------------|
| CRP
diagnostic
assay | CRP Vario | C-reactive protein
immunological
test system | II under 21 CFR
866.5270 | DKC | Immunology |
| CRP
calibrator | CRP Calibrator Set | Calibrator
Primary | II under 21 CFR
862.1150 | JIS | Immunology |
| CRP
calibrator | CRP Calibrator US | Calibrator
Primary | II under 21 CFR
862.1151 | JIS | Immunology |
| CRP
calibrator | CRP Calibrator WR | Calibrator
Primary | II under 21 CFR
862.1152 | JIS | Immunology |
| CRP control | CRP Control US | Quality Control
Material (assayed
and unassayed) | I, reserved,
under 21 CFR
862.1660 | JJY | Clinical
Chemistry |
1
Image /page/1/Picture/0 description: The image shows the logo for Sentinel Diagnostics. The word "SENTINEL" is written in large, bold, stylized letters. Below it, in smaller letters, is the word "DIAGNOSTICS".
5. Device description
The Sentinel CRP Vario kit is a latex in vitro diagnostic immunoassay for the quantitative determination of C-reactive protein (CRP) in human serum and in heparinized and EDTAplasma. Human CRP antigens in the sample bind to the specific anti-CRP antibody absorbed to latex particles, and agglutination occurs. This agglutination is detected as an absorbance change when read on an automated chemistry analyzer at wavelengths between 550 - 580 nm. The magnitude of the change in absorbance is proportional to the quantity of CRP in the sample. The actual concentration is then determined by interpolation from a calibration curve prepared from calibrators of known concentration using the CRP Calibrator Set, CRP Calibrator US, or CRP Calibrator WR.
The Sentinel CRP Calibrator Set, CRP Calibrator US and CRP Calibrator WR are prepared by diluting purified CRP with normal human serum to reach CRP concentrations of 0.25, 0.5, 1.0, 2.0, 4.0, 8.0, 16.0, 32.0 and 48.0 mg/dL.
By using the CRP Vario with the Sentinel calibrator kits, each used with specific analyzer settings called Methods, three measuring ranges can be achieved. The combinations of calibrators, method used and analytical ranges are listed in Table 5.1.
Application Method | Calibrators | Analytical Range |
---|---|---|
Standard Method | CRP Calibrator Set | 0.02 – 32.0 mg/dL |
Ultrasensitive Method | CRP Calibrator Set and | |
CRP Calibrator US | 0.01 – 16.0 mg/dL | |
Wide Range Method | CRP Calibrator Set and | |
CRP Calibrator WR | 0.02 – 48.0 mg/dL |
Table 5.1 Method, calibrators, and analytical ranges for CRP Vario
The Standard and the Wide Range Methods can be used with any available commercial quality control materials. The CRP Vario with the Ultrasensitive Method requires a Sentinel control, CRP Control US, for the approximate CRP concentration of 0.05 mg/dL to ensure the effectiveness of CRP measurements at very low CRP concentrations.
6. Intended Use
CRP Vario is an in vitro diagnostic test for the quantitative determination of C-reactive protein in human serum and lithium heparin or EDTA plasma samples by immunoturbidimetry. Measurement of C-reactive protein is useful in the detection and evaluation of infection, tissue injury and inflammatory disorders.
CRP Calibrators (CRP Calibrator Set, CRP Calibrator US and CRP Calibrator WR) are intended to be used for the calibration of the CRP Vario for the quantitative determination of Creactive protein in human serum and EDTA or lithium heparinized plasma samples.
CRP Control US is intended for use as an assayed quality control material for serum C-reactive protein analysis.
2
7. Comparison with Predicate Devices
Table 7.1 below provides a list of predicate devices for the Sentinel CRP Diagnostic Assay devices.
Table 7.1 Predicate devices for Sentinel CRP DIAGNOSTIC ASSAY devices | |||||||
---|---|---|---|---|---|---|---|
-- | -- | -- | -- | -- | ----------------------------------------------------------------------- | -- | -- |
| | Sentinel Device
Trade Name | Predicate Device
Name | Predicate Device
Manufacturer | Predicate
device (K) | FDA clearance
date |
|----|------------------------------------------------------|----------------------------------------------------|----------------------------------|-------------------------|-----------------------|
| 6 | CRP Vario | CRP-Latex (II)X2
SEIKEN | Denka Seiken Co. | K030545 | 6 Feb. 2003 |
| 7 | CRP Calibrator Set | CRP(II) Calibrators | Denka Seiken Co. | K030546 | 6 Feb. 2003 |
| 8 | CRP Calibrator US
used with CRP
Calibrator Set | CRP(II) Calibrators | Denka Seiken Co. | K030546 | 6 Feb. 2003 |
| 9 | CRP Calibrator WR
used with CRP
Calibrator Set | Immage
Immunochemistry
System CRP
reagent | Beckman Coulter,
Inc. | K981638 | 6 Dec. 1998 |
| 10 | CRP Control US | hsCRP Control
Level 1 | CLINIQA | K011169 | 18 May 2001 |
The Sentinel's CRP reagents, calibrators and control and the predicate devices are both used for the determination of C-Reactive protein. In addition, they use the same::
- Sample type: human serum and plasma .
- Technology: latex particle agglutination .
- Antibody: rabbit polyclonal .
- Detection method: agglutination measurement .
- Calibration: against multipoint calibrators. .
However, CRP Vario must be used with the Abbott AEROSET® and ARCHITECT® analyzers, whereas the Denka Seiken CRP-Latex (II)X2 Assay Kit labeling indicates that the product can be used with any automated clinical chemistry analyzer.
8. Performance Data
Performance evaluations included sensitivity, intra- and inter-assay precision, prozone and interference testing. In addition, Sentinel performed comparisons between the Sentinel CRP assay and the Beckman Coulter IMMAGE Immunochemistry System CRP reagent. Equivalence was demonstrated across the total measurement range of0.01 to 48.0 mg/dL.
9. Conclusion
The performance and safety data presented in this premarket notification support a finding of substantial equivalence between the Sentinel CRP Diagnostic Assay and the predicate devices specified in this submission.
3
DEPARTMENT OF HEALTH & HUMAN SERVICES
Image /page/3/Picture/2 description: The image is a circular seal with the words "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" around the perimeter. Inside the circle is a stylized graphic of three human profiles facing right, stacked on top of each other. The profiles are rendered in a thick, black line, giving them a bold and distinct appearance.
AUG 8 - 2005
Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850
Sentinel CH Srl c/o Maria E. Donawa, M.D. Donawa Consulting Srl Piazza Albania, 10 00153 Rome, Italy
Re: K050836
Trade/Device Name: CRP Calibrators (including CRP Calbrator Set, CRP Calibrator US and CRP Calibrator WR) CRP Vario CRP Control US Regulation Number: 21 CFR 866.5270 Regulation Name: C-reactive protein immunological test system Regulatory Class: Class II Product Code: DCK, JIS, JJY Dated: June 23, 2005 Received: July 6, 2005
Dear Dr. Donawa:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to such additional controls. Existing major regulations affecting your device can be found in Title 21, Code of Federal Regulations (CFR), Parts 800 to 895. In addition, FDA may publish further announcements concerning your device in the Federal Register.
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Parts 801 and 809); and good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820).
4
Page 2 -
This letter will allow you to begin marketing your device as described in your Section 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market.
If you desire specific information about the application of labeling requirements to your device, or questions on the promotion and advertising of your device, please contact the Office of In Vitro Diagnostic Device Evaluation and Safety at (240) 276-0484. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 443-6597 or at its Internet address http://www.fda.gov/cdrh/industry/support/index.html.
Sincerely yours,
Carol C. Benam
Carol C. Benson, M.A. Acting Director Division of Chemistry and Toxicology Office of In Vitro Diagnostic Device Evaluation and Safety Center for Devices and Radiological Health
Enclosure
5
Indications for Use
510(k) Number: K 050836
CRP Calibrators (including CRP Calibrator Set, CRP Calibrator US and CRP Device Name: Calibrator WR)
Indications for Use:
CRP Calibrators (CRP Calibrator Set, CRP Calibrator US and CRP Calibrator WR) are intended to be used for the calibration of the CRP Vario for the quantitative determination of C-reactive protein in human serum and EDTA or lithium heparinized plasma samples.
Prescription Use X (Part 21 CFR 801 Subpart D) AND/OR
Over-The-Counter Use (21 CFR 801 Subpart C)
(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED)
Concurrence of CDRH, Office of In Vitro Diagnostic Devices (OIVD)
Division Sign-Off
Office of In Vitro Diagnostic Device Evaluation and Safety
510(k) K050836
Page 1 of ____________________________________________________________________________________________________________________________________________________________________
6
Indications for Use
510(k) Number: K050836
CRP Vario Device Name:
Indications for Use:
CRP Vario is an in vitro diagnostic test for the quantitative determination of C-reactive protein in human serum and lithium heparin or EDTA plasma samples by immunoturbidimetry. Measurement of C-reactive protein is useful in the detection and evaluation of infection, tissue injury and inflammatory disorders.
Prescription Use × (Part 21 CFR 801 Subpart D) AND/OR
Over-The-Counter Use (21 CFR 801 Subpart C)
(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED)
Concurrence of CDRH, Office of In Vitro Diagnostic Devices (OIVD)
signature
Division Sign-Off
Office of In Vitro Diagnostic Device Evaluation and Safety
5100 K050836
Page 1 of ____________________________________________________________________________________________________________________________________________________________________
7
Indications for Use
150136 K 510(k) Number:
CRP Control US Device Name:
Indications for Use:
CRP Control US is intended for use as an assayed quality control material for serum C-reactive protein analysis.
Prescription Use × (Part 21 CFR 801 Subpart D) AND/OR
Over-The-Counter Use _ (21 CFR 801 Subpart C)
(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED)
Concurrence of CDRH, Office of In Vitro Diagnostic Devices (OIVD)
AC
Division Sign-Off Office of In Vitro Diagnostic Device Evaluation and Safety
510(k) K050836
Page 1 of 1_________________________________________________________________________________________________________________________________________________________________